About the Editors
Like the other Nature titles, Nature Biotechnology has no external editorial board. Instead, all editorial decisions are made by a dedicated team of professional editors with relevant research and editorial backgrounds.
Chief Editor: Andrew Marshall (New York)
Andy obtained his PhD and postdoctoral experience in molecular biology and microbiology at King's College London. Before joining Nature Biotechnology in 1996, he was Editor of Current Opinion in Biotechnology for four years. He has written numerous articles and editorials on science and technology for the popular media, including The Economist, and for trade publications. As well as frequently speaking on biotechnology issues at international meetings, he regularly organizes conferences and symposia for Nature Research in the biotechnology area.
Deputy Editor: Kathy Aschheim (San Francisco)
Kathy did her graduate work in the department of Molecular Biophysics and Biochemistry at Yale University in the laboratory of Thomas Steitz, where she studied DNA and RNA polymerase complexes by X-ray crystallography. She also worked in the laboratory of Steven Smith on structural studies of membrane proteins using solid-state NMR. Before that, Kathy received a PhD in literature from Yale and taught at Northwestern University. She joined the journal in 2001.
Senior Editor: Laura DeFrancesco (Pasadena)
Laura received her PhD at the University of California, San Diego in cell biology and did postdoctoral work on mitochondrial nucleic acids at California Institute of Technology. After doing research for 10 years at the City of Hope National Cancer Center and the University of California, Los Angeles on various topics in animal and cell science, she became the founding editor of the LabConsumer section of The Scientist. Following that, she was managing editor of the web-based life science portal BioResearch Online, and later went on to write for several publications, including Nature Medicine, Analytical Chemistry, and BioIT World. She joined the journal in 2003 and is responsible for Features and Reviews.
Senior Editor: Michael Francisco (New York)
Michael obtained bachelor's degrees in biotechnology and art history from Rutgers University, with concentrations in industrial microbiology and ancient Greek sculpture. He is responsible for Nature Biotechnology's Patents and Careers sections, and also manages social media for the journal. He joined Nature Biotechnology in 1996.
Senior Editor: Markus Elsner (Heidelberg)
Markus did his graduate work at EMBL in Heidelberg, Germany and the University of Gothenburg, Sweden, where he worked on characterizing protein dynamics in living cells. In his postdoctoral studies at the National Institutes of Health he investigated the mechanisms of lipid and protein sorting during membrane transport events. He joined the journal in 2008.
Business Editor: Brady Huggett (New York)
Brady received a Bachelor of Science degree in biology from Wake Forest University and a master's in journalism from the University of North Carolina at Chapel Hill. Prior to joining Nature Biotechnology as business editor in 2007, he was managing editor at the biotech daily news service BioWorld, and he has also worked as a staff writer for a university research magazine. He has written articles covering all aspects of biotech, and has participated in or moderated panel discussions both in the United States and abroad.
Senior News Editor: Lisa Melton (London)
Lisa obtained her PhD at the University of Buenos Aires and did her postdoctoral work at the National Institutes for Medical Research in London, where she investigated thymic differentiation. She then took a science writer's position at the Wellcome Trust and later the Novartis Foundation, contributing to Nature, Scientific American, New Scientist and the Times among others. She joined Nature Biotechnology in 2008.
Associate Editor: Anne Dörr (Berlin)
Anne obtained her Ph.D. at the national institute of Mathematics and Computer Science, Amsterdam, The Netherlands, on modelling of gene expression. She then did a one-year post-doc at the Vrije Universiteit Amsterdam, The Netherlands, on measuring and modeling phenotypic variability. Anne then worked for 5 years at Delft University of Technology, The Netherlands, as a researcher on topics related to building a bottom-up minimal cell, both experimentally and computationally.
Consulting Editor: João Duarte (Berlin)
João obtained a PhD in 2009 from the Universidade de Coimbra and the Instituto Gulbenkian de Ciência, Oeiras, Portugal, for his work on the stability of regulatory T cells in the context of autoimmunity. In his postdoctoral studies at the National Institute for Medical Research, London, UK, he investigated mechanisms of immune tolerance and host–pathogen interactions, including the role of T cells in infection and skin inflammation.
Editorial advisors: John Hodgson, Mark Kessel, Mark Ratner, Chris Scott